PMID- 20164384 OWN - NLM STAT- MEDLINE DCOM- 20100524 LR - 20211203 IS - 1522-1563 (Electronic) IS - 0363-6143 (Linking) VI - 298 IP - 5 DP - 2010 May TI - L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. PG - C982-92 LID - 10.1152/ajpcell.00498.2009 [doi] AB - The development of cell therapeutics from embryonic stem (ES) cells will require technologies that direct cell differentiation to specific somatic cell lineages in response to defined factors. The initial step in formation of the somatic lineages from ES cells, differentiation to an intermediate, pluripotent primitive ectoderm-like cell, can be achieved in vitro by formation of early primitive ectoderm-like (EPL) cells in response to a biological activity contained within the conditioned medium MEDII. Fractionation of MEDII has identified two activities required for EPL cell formation, an activity with a molecular mass of <3 kDa and a second, much larger species. Here, we have identified the low-molecular-weight activity as l-proline. An inhibitor of l-proline uptake, glycine, prevented the differentiation of ES cells in response to MEDII. Supplementation of the culture medium of ES cells with >100 M l-proline and some l-proline-containing peptides resulted in changes in colony morphology, cell proliferation, gene expression, and differentiation kinetics consistent with differentiation toward a primitive ectoderm-like cell. This activity appeared to be associated with l-proline since other amino acids and analogs of proline did not exhibit an equivalent activity. Activation of the mammalian target of rapamycin (mTOR) signaling pathway was found to be necessary but not sufficient for l-proline activity; addition of other activators of the mTOR signaling pathway failed to alter the ES cell phenotype. This is the first report describing a role for amino acids in the regulation of pluripotency and cell differentiation and identifies a novel role for the imino acid l-proline. FAU - Washington, Jennifer M AU - Washington JM AD - Univ. of Melbourne, Victoria, Australia. FAU - Rathjen, Joy AU - Rathjen J FAU - Felquer, Fernando AU - Felquer F FAU - Lonic, Ana AU - Lonic A FAU - Bettess, Michael D AU - Bettess MD FAU - Hamra, Nancy AU - Hamra N FAU - Semendric, Ljiljana AU - Semendric L FAU - Tan, Boon Siang Nicholas AU - Tan BS FAU - Lake, Julie-Anne AU - Lake JA FAU - Keough, Rebecca A AU - Keough RA FAU - Morris, Michael B AU - Morris MB FAU - Rathjen, Peter D AU - Rathjen PD LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100217 PL - United States TA - Am J Physiol Cell Physiol JT - American journal of physiology. Cell physiology JID - 100901225 RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 9DLQ4CIU6V (Proline) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - GMW67QNF9C (Leucine) RN - TE7660XO1C (Glycine) SB - IM CIN - Am J Physiol Cell Physiol. 2010 May;298(5):C979-81. PMID: 20219949 MH - Animals MH - Cell Line MH - Embryonic Stem Cells/*cytology/*physiology MH - Gene Expression Regulation MH - Glycine/pharmacology MH - Humans MH - Intracellular Signaling Peptides and Proteins/genetics/metabolism MH - Leucine/pharmacology MH - Mice MH - Pluripotent Stem Cells/*cytology/*physiology MH - Proline/metabolism/*pharmacology MH - Protein Serine-Threonine Kinases/genetics/metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases EDAT- 2010/02/19 06:00 MHDA- 2010/05/25 06:00 CRDT- 2010/02/19 06:00 PHST- 2010/02/19 06:00 [entrez] PHST- 2010/02/19 06:00 [pubmed] PHST- 2010/05/25 06:00 [medline] AID - ajpcell.00498.2009 [pii] AID - 10.1152/ajpcell.00498.2009 [doi] PST - ppublish SO - Am J Physiol Cell Physiol. 2010 May;298(5):C982-92. doi: 10.1152/ajpcell.00498.2009. Epub 2010 Feb 17.